相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials
Sripal Bangalore et al.
MAYO CLINIC PROCEEDINGS (2016)
Dialysis registries in the world: Korean Dialysis Registry
Dong-Chan Jin
KIDNEY INTERNATIONAL SUPPLEMENTS (2015)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients With Predialysis Advanced Chronic Kidney Disease, Hypertension, and Anemia
Ta-Wei Hsu et al.
JAMA INTERNAL MEDICINE (2014)
Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus AMeta-analysis
Jun Cheng et al.
JAMA INTERNAL MEDICINE (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
2013 ESH/ESC Guidelines for themanagement of arterial hypertension The Task Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC)
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2013)
Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease'
Konrad M. Andrassy
KIDNEY INTERNATIONAL (2013)
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of reninangiotensinaldosterone system inhibitors involving 158 998 patients
Laura C. van Vark et al.
EUROPEAN HEART JOURNAL (2012)
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Brief Report: Renal replacement therapy in Korea, 2010
Dong Chan Jin et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2012)
Impact of Age and Overt Proteinuria on Outcomes of Stage 3 to 5 Chronic Kidney Disease in a Referred Cohort
Yoshitsugu Obi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Evaluating health management programmes over time: application of propensity score-based weighting to longitudinal data
Ariel Linden et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2010)
The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease
Aimun K. Ahmed et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Prevalence of Anemia and Its Impact on Mortality and Hospitalization Rate in Predialysis Patients
N. Voormolen et al.
NEPHRON CLINICAL PRACTICE (2010)
Does Evidence Support Renin-Angiotensin System Blockade for Slowing Nephropathy Progression in Elderly Persons?
Pantelis A. Sarafidis et al.
ANNALS OF INTERNAL MEDICINE (2009)
Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ontargeta call for more circumspection
M. A. C. Onuigbo
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2009)
Interaction of Aging and Chronic Kidney Disease
Suma Prakash et al.
SEMINARS IN NEPHROLOGY (2009)
Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients
Macaulay A. C. Onuigbo et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study):: a multicentre, randomised, double-blind, controlled trial
Johannes F. E. Mann et al.
LANCET (2008)
Aliskiren combined with losartan in type 2 diabetes and nephropathy
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Late onset azotemia from RAAS blockade in CKD patients with normal renal arteries and no precipitating risk factors
Macaulay A. C. Onuigbo et al.
RENAL FAILURE (2008)
Prevalence of chronic kidney disease in the United States
Josef Coresh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease
David M. Kent et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Renoprotection of Optimal Antiproteinuric Doses (ROAD) study: A Randomized controlled study of benazepril and losartan in chronic renal insufficiency
Fan Fan Hou et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
ACE-inhibitor use and the long-term risk of renal failure in diabetes
S Suissa et al.
KIDNEY INTERNATIONAL (2006)
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker
Anastasia Chrysostomou et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Efficacy and safety of benazepril for advanced chronic renal insufficiency
FF Hou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Progression of renal disease: Renoprotective specificity of renin-angiotensin system blockade
Karen A. Griffin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Effect of inhibitors of the renin-angiotensin system and other anti hypertensive drugs on renal outcomes: systematic review and meta-analysis
JP Casas et al.
LANCET (2005)
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease - Results of the African American study of kidney disease and hypertension
J Lea et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic - A report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
M Rahman et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Diabetic nephropathy: Diagnosis, prevention, and treatment
JL Gross et al.
DIABETES CARE (2005)
The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency
CY Hsu et al.
ANNALS OF INTERNAL MEDICINE (2004)
National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
AS Levey et al.
ANNALS OF INTERNAL MEDICINE (2003)
Outcome beyond blood pressure control?
JA Staessen et al.
EUROPEAN HEART JOURNAL (2003)
Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures
MA Hernán et al.
STATISTICS IN MEDICINE (2002)
Association of kidney function with anemia - The Third National Health and Nutrition Examination Survey (1988-1994)
BC Astor et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the physicians' health study
NR Cook et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Epidemiology of anemia associated with chronic renal insufficiency
CY Hsu
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2002)
Comparative effects of ramipril on ambulatory and office blood pressures -: A HOPE substudy
P Svensson et al.
HYPERTENSION (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II
B Pitt et al.
LANCET (2000)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
分享论文
